Please login to the form below

Not currently logged in
Email:
Password:

WCG hires former Roche marketing head

Erik Hawkinson joins comms giant as managing director
WCG Erik Hawkinson

Erik Hawkinson has joined New York-based integrated marketing agency WCG as managing director.

Hawkinson, a former vice president and global head of marketing for Roche, will lead and evolve the company's digital health offerings, said WCG.

Having spearheaded Roche's first e-commerce site, Hawkinson is a globally experienced digital innovator who will be expected to play a key role in WCG's mission to become 'the agency of the future', said Jim Weiss, founder of WCG's parent group W2O.

Hawkinson's background also includes leading digital and e-business initiatives for pharma companies Novartis and Bayer. He serves on the advisory board of the Digital Health Coalition.

“Erik's experience and marketing expertise will contribute directly to our 'next practice' offerings for our healthcare clients when they engage patients, providers and payers anywhere in the world,” said WCG president Chris Deri.

Established more than a decade ago, WCG serves clients through offices in San Francisco, New York, Austin, Los Angeles and London. The agency provides analytics, content, engagement and strategy to clients spanning the consumer, technology, healthcare and pharmaceutical industries.

17th December 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics